Orthocell wins first international approval for nerve repair product
West Australia-based regenerative medicine play Orthocell (ASX: OCC) has received regulatory approval from the Health Sciences Authority in Singapore.
IGB
0.05%
$103.28
ISHARES UBS TREASURY INDEX FUND - Announcements
Currently unlisted.
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results